InsiderTrades.com logo

GUD Insider Trading

Insider Ownership Percentage: 45.62%
Insider Buying (Last 12 Months): C$96,488.48
Insider Selling (Last 12 Months): C$19,733,740.00

Knight Therapeutics Insider Trading History Chart

This chart shows the insider buying and selling history at Knight Therapeutics by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Knight Therapeutics Share Price & Price History

Current Price: C$6.05
Price Change: ▲ Price Increase of +0.01 (0.17%)
As of 12/4/2025 05:00 PM ET

This chart shows the closing price history over time for GUD up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

Knight Therapeutics Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
3/21/2025Sime ArmoyanInsiderSell2,500,000C$6.30C$15,750,000.00
3/19/2025Sime ArmoyanInsiderSell550,000C$6.20C$3,410,000.00
3/17/2025Sime ArmoyanInsiderSell92,200C$6.15C$567,030.00
3/13/2025Sime ArmoyanInsiderSell1,100C$6.10C$6,710.00
3/4/2025Sime ArmoyanInsiderBuy17,600C$5.48C$96,488.48
11/12/2024Sime ArmoyanInsiderBuy90,300C$5.13C$463,672.44
11/11/2024Samira SakhiaDirectorBuy20,000C$5.15C$103,000.00
9/16/2024Sime ArmoyanInsiderSell300,000C$6.13C$1,839,000.00
8/19/2024Amal KhouriSenior OfficerSell5,000C$5.78C$28,919.00
8/15/2024Amal KhouriSenior OfficerSell500C$5.75C$2,875.00
8/13/2024Amal KhouriSenior OfficerSell5,000C$5.75C$28,750.00
7/11/2024Amal KhouriSenior OfficerSell10,000C$5.70C$57,000.00
7/3/2024Amal KhouriSenior OfficerSell10,000C$5.72C$57,200.00
6/10/2024Amal KhouriSenior OfficerSell20,000C$5.80C$116,022.00
6/5/2024Jonathan Ross GoodmanDirectorBuy5,000C$5.80C$29,000.00
5/29/2024Robert Nathaniel LandeDirectorSell15,000C$5.91C$88,600.50
5/23/2024Robert Nathaniel LandeDirectorSell20,000C$5.94C$118,710.00
5/7/2024Sime ArmoyanInsiderSell15,000C$5.95C$89,250.00
4/11/2024Sime ArmoyanInsiderSell10,900C$5.95C$64,855.00
4/1/2024Sime ArmoyanInsiderBuy6,200C$5.25C$32,550.00
3/25/2024Sime ArmoyanInsiderBuy351,000C$5.25C$1,842,750.00
1/22/2024Sime ArmoyanInsiderSell28,200C$5.75C$162,150.00
1/19/2024Sime ArmoyanInsiderSell91,000C$5.75C$523,250.00
10/23/2023Sime ArmoyanInsiderBuy1,100C$4.35C$4,785.00
9/15/2023Sime ArmoyanInsiderBuy26,400C$4.38C$115,737.60
See Full Table

SEC Filings (Institutional Ownership Changes) for Knight Therapeutics (TSE:GUD)

18.36% of Knight Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Knight Therapeutics logo
Knight Therapeutics Inc is a specialty and generic drug manufacturing company. The company's principal business activity is focused on developing, acquiring, in-licensing, out-licensing, marketing, and distributing innovative pharmaceutical products, consumer health products, and medical devices in Canada and select international markets. Knight finances other life sciences companies across the globe in order to generate interest income, strengthen relationships in the life sciences industry, and to secure product distribution rights.
Read More on Knight Therapeutics

Today's Range

Now: C$6.05
Low: C$6.04
High: C$6.09

50 Day Range

MA: C$5.94
Low: C$5.75
High: C$6.24

52 Week Range

Now: C$6.05
Low: C$5.11
High: C$6.55

Volume

20,473 shs

Average Volume

60,403 shs

Market Capitalization

C$600.70 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.011772

Who are the company insiders with the largest holdings of Knight Therapeutics?

Knight Therapeutics' top insider shareholders include:
  1. Amal Khouri (Senior Officer)
  2. Jonathan Ross Goodman (Director)
  3. Robert Nathaniel Lande (Director)
  4. Samira Sakhia (Director)
  5. Sime Armoyan (Insider)
Learn More about top insider investors at Knight Therapeutics.